Paper20814331
Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.
Novalbos J and 5 others. J Clin Psychopharmacol, 2010. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. Papers, record 20814331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20814331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 CYP2D6 | Major topic |
| Polymorphism, Genetic | Major topic |
| Risperidone | Major topic |
| Adult | |
| Alleles | |
| Cross-Over Studies | |
| Dizziness | |
| Female | |
| Genetic Variation | |
| Genotype | |
| Headache | |
| Humans | |
| Male | |
| Young Adult |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 21449670 | Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions. | https://conductscience.org/library/papers/21449670 |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40116580 | Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review. | Pharmacogenomics | 2025 | https://conductscience.org/library/papers/40116580 | PubMed |
| 39832006 | Validating the accuracy of mathematical model-based pharmacogenomics dose prediction with real-world data. | Eur J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/39832006 | PubMed |
| 39505757 | Synergistic Epistasis and Systems Biology Approaches to Uncover a Pharmacogenomic Map Linked to Pain, Anti-Inflammatory and Immunomodulating Agents (PAIma) in a Healthy Cohort. | Cell Mol Neurobiol | 2024 | https://conductscience.org/library/papers/39505757 | PubMed |
| 38375040 | Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38375040 | PubMed |
| 36655374 | Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate. | Clin Transl Sci | 2023 | https://conductscience.org/library/papers/36655374 | PubMed |
| 36597259 | CYP2D6 pharmacogenetics and phenoconversion in personalized medicine. | Expert Opin Drug Metab Toxicol | 2022 | https://conductscience.org/library/papers/36597259 | PubMed |
| 36015360 | Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36015360 | PubMed |
| 34575384 | Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders. | J Clin Med | 2021 | https://conductscience.org/library/papers/34575384 | PubMed |
| 34335273 | Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34335273 | PubMed |
| 33352925 | Application of a Pharmacogenetics-Based Precision Medicine Model (5SPM) to Psychotic Patients That Presented Poor Response to Neuroleptic Therapy. | J Pers Med | 2020 | https://conductscience.org/library/papers/33352925 | PubMed |
| 32015455 | The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis. | Pharmacogenomics J | 2020 | https://conductscience.org/library/papers/32015455 | PubMed |
| 31359271 | Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes. | Clin Pharmacokinet | 2020 | https://conductscience.org/library/papers/31359271 | PubMed |
| 30661084 | CYP2D6 genotype and adverse events to risperidone in children and adolescents. | Pediatr Res | 2019 | https://conductscience.org/library/papers/30661084 | PubMed |
| 29181698 | Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects. | Eur J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29181698 | PubMed |
| 29099060 | Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children. | J Pers Med | 2017 | https://conductscience.org/library/papers/29099060 | PubMed |
| 28512322 | Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine. | Sci Rep | 2017 | https://conductscience.org/library/papers/28512322 | PubMed |
| 28165818 | Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique. | Drug Deliv | 2017 | https://conductscience.org/library/papers/28165818 | PubMed |
| 27942231 | CYP2D6 polymorphisms and their influence on risperidone treatment. | Pharmgenomics Pers Med | 2016 | https://conductscience.org/library/papers/27942231 | PubMed |
| 26937359 | Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort. | Appl Transl Genom | 2015 | https://conductscience.org/library/papers/26937359 | PubMed |
| 26129906 | Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort. | Clin Pharmacokinet | 2015 | https://conductscience.org/library/papers/26129906 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20814331
GET https://conductscience.org/api/papers/v1/20814331/cited_by?page=2